Serum viral status before and after immunosuppressive therapy in the control group
| Patient . | HBsAg . | Anti-HBc IgM . | HBeAg . | Anti-HBe . | HBV DNA . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before . | After . | Before . | After . | Before . | After . | Before . | After . | Before . | After . | |
| A | + | + | − | − | − | − | + | + | NA | NA |
| B | + | + | − | − | + | − | + | + | + | + |
| C | + | + | − | − | + | + | NA | NA | + | + |
| D | + | + | − | − | − | + | − | + | − | + |
| E | + | + | − | + | − | + | + | − | − | + |
| Patient . | HBsAg . | Anti-HBc IgM . | HBeAg . | Anti-HBe . | HBV DNA . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before . | After . | Before . | After . | Before . | After . | Before . | After . | Before . | After . | |
| A | + | + | − | − | − | − | + | + | NA | NA |
| B | + | + | − | − | + | − | + | + | + | + |
| C | + | + | − | − | + | + | NA | NA | + | + |
| D | + | + | − | − | − | + | − | + | − | + |
| E | + | + | − | + | − | + | + | − | − | + |
For abbreviations, see Table 3.